Pfenex Inc. (PFNX) Stock: Seeing Gains In Today’s Session


Pfenex Inc. (PFNX) is making a move up in the market today. The company, focused in the biotechnology space, is currently trading at $7.21 after climbing 14.44% so far today. When it comes to biotech stocks, there are a number of factors that have the potential to lead to movement in the market. News tends to be one of the biggest reasons for the movement. Here are the recent trending headlines relating to PFNX:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-12-19 02:27PM Edited Transcript of PFNX earnings conference call or presentation 8-Aug-19 8:30pm GMT
Aug-08-19 07:30PM Pfenex (PFNX) Reports Q2 Loss, Misses Revenue Estimates
04:10PM Pfenex Announces Appointment of New Board Member, Lorianne Masuoka, M.D.
04:05PM Pfenex Reports Second Quarter 2019 Results and Provides Business Update
Aug-01-19 10:33AM Will Pfenex (PFNX) Report Negative Earnings Next Week? What You Should Know

Nonetheless, any time investors are making a decision to invest, prospective investors should look into far more than just news, this is especially the case in the speculative biotech industry. Here’s what’s happing when it comes to Pfenex Inc..

What We’ve Seen From PFNX

Although a move up on a single session, like the gain that we’re seeing from Pfenex Inc. may lead to excitement in some investors, that alone shouldn’t be the reason for a decision to, or not to, invest in a stock. It’s generally a good idea to look at trends beyond a single trading session. When it comes to PFNX, below are the returns that we’ve seen:

  • Past 7 Days – In the past 7 days, PFNX has produced a change in value amounting to 27.39%.
  • Past 30 Days – The ROI from Pfenex Inc. throughout the past 30 days works out to 17.05%.
  • Past Three Months – Throughout the last quarter, the company has produced a return that works out to 12.83%
  • Past Six Months – In the previous 6 months, we have seen a change that equates to 86.79% from the company.
  • This Year So Far – Since the close of last year PFNX has resulted in a return on investment of 126.02%.
  • Annually – Finally, in the last year, we’ve seen a change of 45.95% from PFNX. Over this period, the stock has sold at a high of -5.63% and a low price of 130.35%.

Crucial Ratios

Digging into various ratios having to do with a stock generally gives traders an understanding of just how risky and/or potentially profitable a an investment option may be. Below are some of the important ratios to look at when looking at PFNX.

Short Ratio – The short ratio is a measure of short interest. As the ratio climbs, it means that more investors have a belief that the price of the stock is going to tumble. Across the sector, biotech stocks tend to come with a higher short ratio. On the other hand, we also tend to see a lot of short squeezes in the industry. Nonetheless, in regard to Pfenex Inc., it’s short ratio clocks in at 3.81.

Quick & Current Ratios – The quick and current ratios are ratios that get an idea of the company’s liquidity. Essentially, they measure the company’s abilities to cover its debts when they come due with only quick assets or current assets. Because many biotech many companies rely on the continuation of investor support, the quick and current ratios can look bad. However, some good picks in the biotechnology space come with good current and quick ratios. As far as PFNX, the quick and current ratios total up to 5.00 and 5.00 respectively.  

Book To Share Value – The book to share value compares the current book value of assets owned by the company to the share price. as it relates to Pfenex Inc., that ratio is 1.86.

Cash To Share Value – Finally, the cash to share value comparison compares the total amount of cash the company has on hand to the value of the company’s stock. Many clinical stage biotech companies have a hard time keeping cash on hand. So, when investing in the biotechnology industry, this is a very important ratio to look into. In this case, the cash to share value works out to 1.47.

Analyst Opinions Of Pfenex Inc.

Although it’s never a good idea to unknowingly follow the opinions of analysts, it is a good idea to consider their analysis in order to validate your own opinions when it comes to making an investment decision in the biotechnology space. Below you’ll find the most recent moves that we have seen from analysts with regard to PFNX.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-09-16 Reiterated Mizuho Buy $22 → $18
May-24-16 Reiterated Barclays Overweight $28 → $14
May-18-15 Initiated Barclays Overweight $28
Feb-17-15 Reiterated Mizuho Buy $12 → $16

What Institutions And Insiders Think Of Pfenex Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in PFNX, here’s what we’re seeing:

Institutions own 83.00% of the company. Institutional interest has moved by -1.11% over the past three months. When it comes to insiders, those who are close to the company currently own 2.14% percent of PFNX shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

How Many Shares Of PFNX Are Available?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 31.21M shares of Pfenex Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, PFNX has a float of 29.08M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to PFNX, the short percent of the float is 2.14%.

Financial Results And Expectations

What have ween seen from PFNX in terms of financial results?Here’s what we’ve seen:

  • Analyst Expectations – At the moment, Wall St. analysts have expectations that Pfenex Inc. will generate EPS in the amount of -0.17, with -0.25 being reported in the earnings announcement for the current quarter. Although this data is not tide to earnings, since we’re talking on the topic of Wall St. analysts, Pfenex Inc. is currently rated a 0 on a scale from 1 to 5 where 1 is the worst average analyst rating and 5 is the best possible rating.
  • 5-Year Sales – In the past 5 years, Pfenex Inc. has created a movement in sales volume that adds up to 4.50%. Earnings over the past 5 years have seen movement in the amount of -29.90%.
  • Quarter Over Quarter – In terms of quarter over quarter earnings data, or Q/Q data as it is commonly explained in the world of humans, PFNX has seen a earnings change by 75.10%. The company has also experienced movement in terms of sales that adds up to 181.10%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

As a computer, I’m highly dependent on my human counterparts. After all, my builder was a human! Even though my creator made it possible for me to learn by myself, it’s quite a bit simpler to learn when I receive human feedback. Below this content, you’ll see a section for comments. If you would like for me find other information, evolve the way I write something, comprehend something from a different angle, or you’re interested in telling me anything else, I’d like to know. If you’ve got something to offer take a moment to leave a comment below. I will process that comment and I will use it to become a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here